Diosmetin inhibits osteoclast formation and differentiation and prevents LPS-induced osteolysis in mice

Siyuan Shao1, Fangsheng Fu1, Ziyi Wang2

  • 1Research Centre for Regenerative Medicine, Guangxi Key Laboratory of Regenerative Medicine, Guangxi Medical University, Nanning, Guangxi, China.

Insights

Diosmetin (DIO) effectively inhibits osteoclast formation and bone resorption, offering a potential treatment for osteolytic bone diseases. This natural flavonoid reduces key markers and pathways involved in bone breakdown.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Osteolytic bone diseases involve excessive osteoclast activity and bone resorption, posing significant clinical challenges.
  • Current treatments focus on inhibiting osteoclasts, but novel therapeutic agents are needed.
  • Diosmetin (DIO), a natural flavonoid, possesses antioxidant and anti-inflammatory properties, but its effect on osteoclast differentiation is largely unknown.

Purpose of the Study:

  • To investigate the effect of Diosmetin (DIO) on osteoclast differentiation and bone resorption.
  • To elucidate the molecular mechanisms underlying DIO's action on osteoclasts.
  • To evaluate the therapeutic potential of DIO in an in vivo model of osteolysis.

Main Methods:

  • Osteoclast differentiation was induced by receptor activator of nuclear factor kappa-B ligand (RANKL) in vitro.
  • Gene expression of osteoclast markers (cathepsin K, NFATc1, Acp5, Ctr, Atp6v0d2, Mmp9) was analyzed.
  • Actin ring formation and bone resorption assays were performed.
  • Western blotting assessed signaling pathways (MAPK) and transcription factors (NFATc1, c-Fos).
  • Reactive oxygen species (ROS) levels were measured.
  • An in vivo mouse model of lipopolysaccharide (LPS)-induced osteolysis was used.

Main Results:

  • DIO dose-dependently inhibited RANKL-induced osteoclast formation.
  • DIO decreased the expression of key osteoclast differentiation markers.
  • DIO attenuated actin ring formation and bone resorption.
  • DIO inhibited the RANKL-induced MAPK signaling pathway and downregulated NFATc1 and c-Fos.
  • DIO reduced RANKL-induced ROS accumulation.
  • DIO significantly ameliorated LPS-induced osteolysis in mice.

Conclusions:

  • Diosmetin (DIO) effectively inhibits osteoclast formation and activation.
  • DIO acts by suppressing the MAPK signaling pathway and reducing ROS production.
  • DIO demonstrates therapeutic potential as a novel agent for treating osteolytic bone diseases.

Related Concept Videos

Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.2K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.1K
Formation of Species01:31

Formation of Species

Speciation describes the formation of one or more new species from one or sometimes multiple original species. The resulting species are discrete from the parent species, and barriers to reproduction will typically exist. There are two primary mechanisms, speciation with and without geographic isolation—allopatric and sympatric speciation, respectively.
45.1K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.4K
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.3K